4 Projects | 3 Researchers | $3,599,379 Invested
2022
Wake Forest University Health Sciences
Miranda Orr, PhD
Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Senescence Biomarker Discovery
2020
Wake Forest University Health Sciences
Miranda Orr, PhD
Phase II Clinical Trial to Evaluate the Safety and Feasibily of Senolytic Therapy in Alzheimer's Disease
2007
Wake Forest University Health Sciences
Sally Shumaker, PhD
11th Biennial Graylyn Conference on Women's Cognitive Health
2002
Wake Forest University Health Sciences
James Toole, PhD
Planning for A Prospective, Randomized Study for the Prevention & Treatment of Post-Stroke Dementia